JANS Working Group

The working group developed the JANS tool and guidelines in 2009. In 2011 the group reconvened to amend the tool and guidelines, based on country experience. In 2011 it also developed an options paper on how to conduct a JANS, based on experience.

Agencies and countries represented on the original JANS Inter-Agency Working Group and the subsequent JANS Amendment Group include:  Australia; African Council for Sustainable Health Development (ACOSHED); Ministry of HIV & AIDS, Burundi;  Ministry of Health, Ethiopia; European Commission; GAVI Alliance; Integrated Social Development Centre, Ghana; Ministry of Health, Ghana; Global Fund to Fight AIDS, TB and Malaria; Health Global Access Project; Ministry of Health, Mali; Ministry of Foreign Affairs, The Netherlands; Roll Back Malaria; Ministry of Foreign Affairs, Spain; Treatment Action Group; Ministry of Health, Uganda; UNAIDS; UNFPA; UNICEF; Department for International Development, United Kingdom; World Bank; World Health Organization.

Visit JANS page

Monitoring and Evaluation Working Group

The M&E working group, led by WHO, has developed the common IHP+ evaluation framework, which has led into a country guidance document: Monitoring, evaluation and review of national health strategies: a common platform for information and accountability. These are now being used by countries and by global initiatives including the Commission on Information & Accountability For Womens’ and Childrens’ Health.

Members: Peter Hansen (GAVI), Daniel Low-Beer (Global Fund), Laura Laski (UNFPA), Holly Newby (UNICEF), Jennifer Bryce (JHU, Countdown), Finn Schleimann (World Bank), Regina Keith (World Vision), Isabella Danel (CDC), Erin Eckert (USAID), Shaun Conway (IHP+Results), Veronica Walford; Ties Boerma and Kathy O'Neill (WHO), Don de Savigny (Univ of Basel), Peter Ghys (UNAIDS), Lola Dare (ACOSHED), Wim van Damme (Univ of Antwerp);

Visit the Monitoring and Evaluation page

Costings Working Group

The Inter-Agency Working Group (IAWG) on Costing has reviewed existing planning, costing and budgeting tools and has developed a single UN tool. The OneHealth Tool is a tool to support the costing, budgeting, financing and development of national health sector strategies in developing countries. IAWG-Costing will further develop the tool to include additional modules for health information systems, governance and non-communicable diseases.

Working Group Members: UNAIDSUNDPUNFPAUNICEF, WHO and World Bank.

Procurement Working Group

In 2009, the IHP+ Ministerial Review communiqué included an action point on the harmonization of procurement policies. As a manageable first step on the harmonization agenda, a time-limited working group with a specific focus on harmonizing procurement standards for medical goods between international organizations was created in 2010, to address quality assurance concerns. This group reported to the Interagency Pharmaceutical Coordination Group (IPC) as the leading technical body, and to the IHP+ Executive Team to facilitate discussion by the wider policy community. The group was led by The Global Fund and WHO. It included World Bank, UNICEF, European Commission (ECHO), USAID, MSH, MSF, ICRC, QUAMED, Crown Agents and others.

The resulting paper, discussing approaches to assure quality of essential medicines procured with donor funds, is now available: “Assuring the Quality of Essential Medicines Procured with Donor Funds”.

Findings and next steps were discussed by 17 organizations including donors, UN agencies, key procurement service agencies and NGOs, at a meeting in August 2011. 

In June 2012 the IHP+ Executive Team was briefed on the work. The ET reconfirmed that this is an important issue needing continued IHP+ support. It discussed two types of action, and where IHP+ could be useful:

  • Global: A group led by The Global Fund and WHO is developing a methodology for a ”pre-qualification” of procurement agencies, as part of a differentiated approach to quality assurance that is endorsed via the IPC. Agencies then would need to implement this, which is where IHP+ can play a role. 

  • Country level: Strengthening capacity of national regulatory authorities for quality assurance is key. The role of IHP+ in this will need further elaboration.

This topic was on the agenda at the 4th IHP+ Country Health Teams Meeting in December 2012.